Ichor Vascular has filed a notice of an exempt offering of securities to raise $6,000,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Ichor Vascular is raising up to $6,000,000.00 in new funding. Sources indicate that as part of senior management Senior Executive, Jeff Blair played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Ichor Vascular
Disruptive: Safe and effective products to treat vascular occlusions and achieve reperfusion .. with simplicity! Innovative: Minimally invasive systems easily adoptable by physicians, hospitals, and office based labs. Improve Outcomes: Reduces or eliminates surgical and drug complications. Better Economics: Technologies aimed at transforming outcomes and the economics in treating vascular occlusions.
To learn more about Ichor Vascular, visit http://ichorvascular.com/
Contact:
Jeff Blair, Senior Executive
574-527-4227
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.